Nomi Health’s Post

With GLP-1 medications projected to become the costliest drug category within three years, employers face a challenge. How can they support employee health while managing costs? Our Trends in Spend analysis provides insights into utilization trends and cost drivers, helping employers make informed decisions about their health plans. Discover strategies for balancing health and costs: https://lnkd.in/gR4fgZKc

We had a fantastic time at the Medicaid Enterprise Systems Community event in Louisville, KY, exchanging ideas about Medicaid systems — and the health policies impacted by those systems.   Here's our team at the event (L-R): Anna Volk, Makae Wright, Colleen Rooney and Alexander Bueno.

Since acquiring Artemis in 2022, Nomi Health has expanded to offer networks, pharmacy services (CerpassRx), healthcare financial services, and integrated care programs. Now, with Betsy McVay leading Artemis by Nomi Health, we're enhancing these services with robust data capabilities. Learn about our comprehensive approach: https://lnkd.in/giH9nawZ

Nomi Health is recognized as one of Utah Business's 2024 #Fast50 Emerging Companies! The full feature is in Utah Business magazine’s September issue: https://lnkd.in/gPk9JPsh Congratulations to our fellow honorees, and thank you to our team and partners for your support of our bold mission!

"We don't have a single-payer system in America, but we do have a single administrator, and that's a catastrophic vulnerability." These words from Boe Hartman, co-founder and CTO of Nomi Health, highlight our healthcare system's fragility. At Nomi Health, we've been speaking out about this issue since the hack on February 21. Boe's analysis, drawing on his background as a veteran of financial technology, reveals how this single point of failure threatens us all. Read Boe's analysis: https://lnkd.in/gWEGdUiA MedCity News #ChangeHealthcare #DataBreach #HealthcareFinance

Welcome, Scott Williams, to the Nomi Health Global Sales team. He brings 28 years of experience in the commercial healthcare industry to Nomi. With a successful tenure at UnitedHealthcare, Scott built a strong background in underwriting, operations and health plan leadership along with 18 years of leading the sales and account management team at UnitedHealthcare for Iowa and Central Illinois. His knowledge of the ASO marketplace, TPAs and network development position him for success in global sales at Nomi Health. Scott currently resides in Bettendorf, Iowa.

Nomi Health Co-Founder and CEO Mark Newman says prescription spending is increasing too much, too fast for self-funded employers. “It’s a significant punch in the gut to a company’s finances. This cost crisis threatens the quality of their employee benefits. Most of all, it's completely avoidable. There are solutions here and now that enable employers to cut prescription spending in half while making sure employees get the treatments they need.” Read more: https://lnkd.in/gR_jCujm #SelfFunded #EmployeeBenefits #HealthcareCosts

Our Artemis by Nomi Health platform, now led by Betsy McVay, serves over 1,000 companies and influences $46 billion in annual health spend. Discover how Betsy and our analytics team are making data-driven healthcare more accessible and impactful: https://lnkd.in/gfuZg7vt #DataAnalytics #HealthcareBenefits

Did you know employers spent over $900 million on just the top three GLP-1 drugs in 2023? Ozempic led with $372M, followed by Wegovy at $261M and Mounjaro at $256M. As these costs continue to climb, employers need to work closely with analytics partners and PBMs to develop comprehensive drug management strategies. Here's our guide for employers on creating a GLP-1 strategy: https://lnkd.in/gR4fgZKc #EmployeeBenefits #HealthyEmployees #DataAnalytics